An immunotherapy based on autologous cancer cells extended the expected life span of dogs with canine osteosarcoma, researchers at the University of Missouri College of Veterinary Medicine report, and veterinarians are starting a larger clinical trial. The FDA also approved a clinical trial to test the approach in people with glioblastoma multiforme, an aggressive type of brain cancer.
Immunotherapy lengthens lives of dogs with bone cancer
Sign up for FBR SmartBrief
Biomedical Research News
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.